| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.30B | 37.55B | 32.86B | 20.91B | 29.61B | 33.53B |
| Gross Profit | 21.57B | 32.51B | 24.11B | 20.91B | 19.86B | 33.53B |
| EBITDA | 13.36B | 20.83B | 8.21B | ― | 3.76B | ― |
| Net Income | 9.84B | 9.26B | 5.21B | 4.61B | 2.79B | 9.40B |
Balance Sheet | ||||||
| Total Assets | 761.79B | 741.86B | 697.60B | 635.44B | 613.12B | 601.01B |
| Cash, Cash Equivalents and Short-Term Investments | 42.47B | 37.00B | 253.03B | 218.64B | 230.55B | 238.33B |
| Total Debt | 355.96B | 373.41B | 77.25B | 169.58B | 179.22B | 198.64B |
| Total Liabilities | 618.81B | 601.63B | 564.25B | 506.64B | 496.44B | 493.96B |
| Stockholders Equity | 114.25B | 111.65B | 104.78B | 100.15B | 95.04B | 95.22B |
Cash Flow | ||||||
| Free Cash Flow | -1.26B | 1.68B | 25.88B | 68.66B | 36.71B | -41.28B |
| Operating Cash Flow | -838.71M | 2.09B | 26.42B | 69.25B | 37.18B | -40.82B |
| Investing Cash Flow | 26.28B | 9.43B | 15.65B | -75.42B | -17.94B | 32.04B |
| Financing Cash Flow | 31.78B | 13.17B | -11.29B | -8.82B | -17.98B | 31.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$151.67B | 5.14 | 10.09% | 0.97% | 8.40% | 78.28% | |
68 Neutral | HK$179.48B | 4.86 | 10.70% | 2.80% | 2.39% | 46.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$156.03B | 7.74 | 10.10% | 3.83% | 38.36% | 19.98% | |
63 Neutral | HK$180.83B | 6.38 | 9.27% | 2.92% | 28.52% | 6.24% | |
61 Neutral | HK$72.14B | 7.25 | 6.25% | 2.66% | 14.46% | 25.89% | |
54 Neutral | HK$122.85B | 6.39 | 8.68% | 2.89% | -21.60% | 73.59% |